Home>
US Stocks>
Puretech Health Plc - Adr

Puretech Health Plc - Adr share price today

(PRTC)

Puretech Health Plc - Adr share price is $22.1 & ₹1,871.65 as on 7 Dec 2024, 2.30 'hrs' IST

$22.1

▲

1.07

(5.09%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Puretech Health Plc - Adr share price in Dollar and Rupees. Guide to invest in Puretech Health Plc - Adr from India. Also see the sentimental analysis on Indian investors investing in Puretech Health Plc - Adr. Get details on the Indian mutual funds that are investing in Puretech Health Plc - Adr. Get Analyst recommendations and forecasts along with all the Puretech Health Plc - Adr's financials.

Puretech Health Plc - Adr share price movements

$21.30
$23.69
$22.10
3.62%
Downside
Day's Volatility :10.09%
Upside
6.71%
$17.08
$34.00
$22.10
22.71%
Downside
52 Weeks Volatility :49.76%
Upside
35.0%

Puretech Health Plc - Adr Returns

Period	Puretech Health Plc - Adr	Sector (Health Care)	Index (Russel 2000)
3 Months	-2.91%	-5.7%	0.0%
6 Months	-27.93%	-0.9%	0.0%
1 Year	16.83%	10.0%	0.0%
3 Years	-47.03%	9.3%	-21.5%

Puretech Health Plc - Adr Key Statistics

in dollars & INR

Previous Close	$21.03
Open	$23.67
Today's High	$23.69
Today's Low	$21.3
Market Capitalization	$492.3M
Today's Volume	$1.8K
52 Week High	$34.0
52 Week Low	$17.08
Revenue TTM	$468.0K
EBITDA	$-134.7M
Earnings Per Share (EPS)	$-2.87
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.62%
Return On Equity TTM	-22.07%

How to invest in Puretech Health Plc - Adr from India?

It is very easy for Indian residents to invest directly in Puretech Health Plc - Adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Puretech Health Plc - Adr stock in both rupees (INR) and dollars (USD). Search for Puretech Health Plc - Adr or PRTC on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Puretech Health Plc - Adr or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Puretech Health Plc - Adr shares which would translate to 0.038 fractional shares of Puretech Health Plc - Adr as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Puretech Health Plc - Adr

40%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Puretech Health Plc - Adr on INDmoney from India has grown in the last 30 days as on Dec 7, 2024. 40% more investors are searching Puretech Health Plc - Adr in the last 30 days versus the previous period.

Global Institutional Holdings in Puretech Health Plc - Adr

Pentwater Capital Management LP
0.10%
ADAR1 Capital Management LLC
0.01%

Analyst Recommendation on Puretech Health Plc - Adr

Buy

83%Buy

16%Hold

0%Sell

Based on 6 Wall street analysts offering stock ratings for Puretech Health Plc - Adr(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Puretech Health Plc - Adr

What analysts predicted

Upside of 138.69%

Current:

$22.10

Target:

$52.75

Insights on Puretech Health Plc - Adr

Increasing Revenue
Revenue is up for the last 3 quarters, 90.0K → 144.0K (in $), with an average increase of 18.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -20.34M → -20.88M (in $), with an average decrease of 1.3% per quarter
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 42.1% return, outperforming this stock by 19.0%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 39.7% return, outperforming this stock by 86.8%

Puretech Health Plc - Adr Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$16.4M	↑ 2418.62%
Net Income	$-43.7M	↓ 241.42%
Net Profit Margin	-266.65%	↓ 5015.73%

	FY19	Y/Y Change
Revenue	$8.7M	↓ 46.93%
Net Income	$421.1M	↓ 1064.73%
Net Profit Margin	4.8K%	↑ 5114.07%

	FY20	Y/Y Change
Revenue	$8.3M	↓ 3.99%
Net Income	$4.6M	↓ 98.92%
Net Profit Margin	54.77%	↓ 4792.65%

	FY21	Y/Y Change
Revenue	$10.0M	↑ 19.64%
Net Income	$-62.7M	↓ 1472.79%
Net Profit Margin	-628.41%	↓ 683.18%

	FY22	Y/Y Change
Revenue	$2.1M	↓ 79.06%
Net Income	$-37.1M	↓ 40.9%
Net Profit Margin	-1.8K%	↓ 1144.99%

	FY23	Y/Y Change
Revenue	$3.3M	↑ 59.33%
Net Income	$-65.7M	↑ 77.25%
Net Profit Margin	-2.0K%	↓ 199.48%

	Q1 FY23	Q/Q Change
Revenue	$1.6M	-
Net Income	$-12.5M	-
Net Profit Margin	-793.78%	-

	Q2 FY23	Q/Q Change
Revenue	$3.2M	↑ 100.0%
Net Income	$-25.0M	↑ 100.01%
Net Profit Margin	-793.81%	↓ 0.03%

	Q3 FY23	Q/Q Change
Revenue	$90.0K	↓ 97.14%
Net Income	$-20.3M	↓ 18.63%
Net Profit Margin	-22.6K%	↓ 21813.41%

	Q1 FY24	Q/Q Change
Revenue	$144.0K	↑ 60.0%
Net Income	$-20.9M	↑ 2.65%
Net Profit Margin	-14.5K%	↑ 8102.71%

	Q2 FY24	Q/Q Change
Revenue	$144.0K	↑ 0.0%
Net Income	$-20.9M	↑ 0.0%
Net Profit Margin	-14.5K%	↑ 0.0%

	FY18	Y/Y Change
Total Assets	$441.8M	↑ 29.99%
Total Liabilities	$274.8M	↓ 0.38%

	FY19	Y/Y Change
Total Assets	$941.2M	↑ 113.05%
Total Liabilities	$290.8M	↑ 5.82%

	FY20	Y/Y Change
Total Assets	$990.0M	↑ 5.19%
Total Liabilities	$336.5M	↑ 15.71%

	FY21	Y/Y Change
Total Assets	$946.0M	↓ 4.44%
Total Liabilities	$361.9M	↑ 7.55%

	FY22	Y/Y Change
Total Assets	$702.6M	↓ 25.72%
Total Liabilities	$155.1M	↓ 57.15%

	FY23	Y/Y Change
Total Assets	$694.0M	↓ 1.23%
Total Liabilities	$235.7M	↑ 52.03%

	Q1 FY23	Q/Q Change
Total Assets	$693.6M	↓ 1.29%
Total Liabilities	$184.7M	↑ 19.09%

	Q2 FY23	Q/Q Change
Total Assets	$693.6M	↑ 0.0%
Total Liabilities	$184.7M	↑ 0.0%

	Q3 FY23	Q/Q Change
Total Assets	$694.0M	↑ 0.06%
Total Liabilities	$235.7M	↑ 27.66%

	Q4 FY23	Q/Q Change
Total Assets	$694.0M	↑ 0.0%
Total Liabilities	$235.7M	↑ 0.0%

	Q1 FY24	Q/Q Change
Total Assets	$580.0M	↓ 16.43%
Total Liabilities	$273.7M	↑ 16.12%

	Q2 FY24	Q/Q Change
Total Assets	$580.0M	↑ 0.0%
Total Liabilities	$273.7M	↑ 0.0%

	FY18	Y/Y Change
Operating Cash Flow	$-72.8M	↓ 17.92%
Investing Cash Flow	$-39.6M	↓ 147.38%
Financing Cash Flow	$156.9M	↑ 967.55%

	FY19	Y/Y Change
Operating Cash Flow	$-98.2M	↑ 34.84%
Investing Cash Flow	$63.7M	↓ 260.57%
Financing Cash Flow	$49.9M	↓ 68.19%

	FY20	Y/Y Change
Operating Cash Flow	$-131.8M	↑ 34.3%
Investing Cash Flow	$364.5M	↑ 472.55%
Financing Cash Flow	$38.9M	↓ 22.12%

	FY21	Y/Y Change
Operating Cash Flow	$-158.3M	↑ 20.06%
Investing Cash Flow	$197.4M	↓ 45.85%
Financing Cash Flow	$22.7M	↓ 41.53%

	Q4 FY22	Q/Q Change
Operating Cash Flow	$-32.6M	↓ 28.85%
Investing Cash Flow	$86.9M	↑ 0.0%
Financing Cash Flow	$45.9M	↓ 480.34%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-32.6M	↑ 0.0%
Investing Cash Flow	$86.9M	↑ 0.0%
Financing Cash Flow	$45.9M	↑ 0.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-65.1M	↑ 100.0%
Investing Cash Flow	$86.9M	↑ 0.0%
Financing Cash Flow	$91.9M	↑ 100.0%

Puretech Health Plc - Adr Technicals Summary

Sell

Neutral

Buy

Puretech Health Plc - Adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Puretech Health Plc - Adr Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Puretech Health Plc - Adr	1.11%	-27.93%	16.83%	-47.03%	-57.04%
Regeneron Pharmaceuticals, Inc.	-6.86%	-23.34%	-8.6%	17.41%	110.02%
Biontech Se	10.16%	21.29%	14.9%	-59.29%	309.79%
Alnylam Pharmaceuticals, Inc.	-7.5%	64.08%	48.09%	42.33%	108.61%
Vertex Pharmaceuticals Incorporated	-8.46%	-4.83%	31.35%	122.6%	109.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Puretech Health Plc - Adr	NA	NA	NA	-4.31	-0.22	-0.13	NA	1.32
Regeneron Pharmaceuticals, Inc.	18.56	18.56	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Puretech Health Plc - Adr	Buy	$492.3M	-57.04%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$82.9B	110.02%	18.56	33.61%
Biontech Se	Buy	$28.5B	309.79%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	108.61%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$118.4B	109.65%	32.84	-4.51%

About Puretech Health Plc - Adr

PureTech Health is a biotechnology company which develops medicines to combat serious diseases.

Organization	Puretech Health Plc - Adr
Employees	90
CEO	Dr. Bharatt M. Chowrira J.D., Ph.D.
Industry	Health Technology

Management People of Puretech Health Plc - Adr

Name	Title
Dr. Bharatt M. Chowrira J.D., Ph.D.	CEO & Executive Director
Ms. Daphne Zohar	Founder, Senior Advisor & Board Observer
Dr. Robert S. Langer Jr., Ph.D., ScD	Co-Founder & Non-Executive Director
Dr. Eric Elenko Ph.D.	Co-Founder & President
Dr. David R. Elmaleh Ph.D.	Co-Founder & Senior Advisor
Ms. Lauren A. White M.B.A.	Chief Financial Officer
Mr. Eric Green M.B.A.	Chief Operating Officer
Ms. Allison Mead Talbot	Head of Communications & Investor Relations
Mr. Charles Sherwood III, J.D., Ph.D.	General Counsel & Company Secretary
Mr. Spencer Ball	Senior Vice President of Human Resources

Important FAQs about investing in Puretech Health Plc - Adr from India :

What is Puretech Health Plc - Adr share price today?

Puretech Health Plc - Adr (PRTC) share price today is $22.10.

Can Indians buy Puretech Health Plc - Adr shares?

Yes, Indians can invest in the Puretech Health Plc - Adr (PRTC) from India.

With INDmoney, you can buy Puretech Health Plc - Adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Puretech Health Plc - Adr at zero transaction cost.

How can I buy Puretech Health Plc - Adr shares from India?

It is very easy to buy Puretech Health Plc - Adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Puretech Health Plc - Adr be purchased?

Yes, you can buy fractional shares of Puretech Health Plc - Adr with INDmoney app.

What are the documents required to start investing in Puretech Health Plc - Adr stocks?

To start investing in Puretech Health Plc - Adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.